Ausdiagnostics Uk Limited in Chesham, HP5 2QA

Description

Data updated on: 01-11-2023

Registered with number 08507496 eleven years ago, Ausdiagnostics Uk Limited is categorised as a Private Limited Company. The active mailing address is Unit 3 Anglo Business Park, Asheridge Road Chesham. This enterprise's classified under the NACE and SIC code 26600 - Manufacture of irradiation, electromedical and electrotherapeutic equipment. 2022/06/30 is the last time when the accounts were filed.

Scott G. is the enterprise's individual managing director, that was formally appointed in 2022 in March. That firm had been controlled by Marco C. until 5th February 2024. Furthermore a different director, including Richard H. quit in 2021.

Ralph D. is the individual who controls this firm, owns over 1/2 to 3/4 of company shares and has over 1/2 to 3/4 of voting rights.

Financial data based on annual reports

Profit & Loss
Date of Accounts	2014-06-30	2015-06-30	2016-06-30	2017-06-30	2018-06-30	2019-06-30	2020-06-30	2021-06-30	2022-06-30
Currency
Net Worth	-2 742	-79 857	-180 508

Balance Sheet
Cash Bank On Hand			13 114	35 082	109 194	119 502	629 020	2 399 024
Current Assets	151 155	333 458	380 626	402 466	772 427	882 153	2 778 980	5 449 801
Debtors	17 312	27 549	241 346	205 559	329 808	490 785	1 409 152	1 473 327
Net Assets Liabilities						108 606	1 696 623	4 706 564
Other Debtors			42 871	27 341	22 272	20 000	26 314	20 045
Property Plant Equipment			375 661	454 110	341 588	384 162	594 270	758 298
Total Inventories			126 166	161 825	333 425	271 866	740 808	1 577 450	1 760 176
Cash Bank In Hand	9 817	8 134	13 114
Net Assets Liabilities Including Pension Asset Liability	-2 742	-79 857	-180 508
Stocks Inventory	124 026	297 775	126 166
Tangible Fixed Assets	774	17 800	375 663

Capital & Reserves
Called Up Share Capital	1	1	1
Profit Loss Account Reserve	-2 743	-79 858	-180 509
Shareholder Funds	-2 742	-79 857	-180 508

Other Financial Data
Audit Fees Expenses								25 500
Accrued Liabilities Deferred Income							8 244	60 951
Accumulated Amortisation Impairment Intangible Assets							73 792	163 863
Accumulated Depreciation Impairment Property Plant Equipment			55 315	168 458	289 665	464 523	591 074	868 921	1 358 756
Acquired Through Business Combinations Intangible Assets
Additions Other Than Through Business Combinations Intangible Assets								154 648
Additions Other Than Through Business Combinations Property Plant Equipment							415 153	481 734	234 517
Administrative Expenses							1 114 775	2 100 337	2 292 364
Amortisation Expense Intangible Assets							73 792	90 071
Amounts Owed By Group Undertakings							229 249	493 359
Amounts Owed By Other Related Parties Other Than Directors								493 359	3 534 963
Amounts Owed By Parent Entities
Amounts Owed By Related Parties							229 249
Amounts Owed To Group Undertakings			876 317	1 112 353	1 025 455	1 024 524	684 529	576 959
Average Number Employees During Period						12	13	23	28
Cash Cash Equivalents								2 399 024	1 193 007
Comprehensive Income Expense							1 561 217
Corporation Tax Payable							335 017	411 933
Cost Inventories Recognised As Expense Gross									2 042 776
Cost Sales							2 058 113	3 288 026	2 245 313
Creditors			936 795	1 188 373	1 074 193	1 157 709	235 560	291 123
Current Tax For Period							349 916	711 933
Deferred Tax Expense Credit From Unrecognised Timing Difference From Prior Period								13 513
Deferred Tax Expense Credit Relating To Origination Reversal Temporary Differences									20 230
Deferred Tax Expense Credit Relating To Origination Reversal Timing Differences							23 168	13 513
Deferred Tax Liabilities							38 067	51 580	71 810
Depreciation Expense Property Plant Equipment							192 185	295 801
Finance Lease Liabilities Present Value Total							235 560	291 123
Finance Lease Payments Owing Minimum Gross							285 599	371 874
Finished Goods								1 577 450	1 760 176
Finished Goods Goods For Resale							740 808	1 577 450
Fixed Assets	774	17 800	375 663				982 758	1 211 363
Further Item Tax Increase Decrease Component Adjusting Items								42 992
Future Minimum Lease Payments Under Non-cancellable Operating Leases					673 750	675 000	615 000
Gain Loss Due To Foreign Exchange Differences Recognised In Profit Or Loss							9 618	-31 616
Gain Loss On Disposals Property Plant Equipment							33 326	-24 561
Gross Profit Loss							3 049 076	5 905 517
Increase Decrease In Current Tax From Adjustment For Prior Periods								42 993
Increase From Amortisation Charge For Year Intangible Assets								90 071
Increase From Depreciation Charge For Year Property Plant Equipment				113 312	153 360	177 576	192 185	295 801	286 924
Intangible Assets							388 488	453 065
Intangible Assets Gross Cost							462 280	616 928	616 928
Net Current Assets Liabilities	-3 516	-97 657	-556 171	-785 907	-301 766	-275 556	1 090 381	3 968 786
Number Shares Issued Fully Paid				1	1
Other Creditors			42 684	2 872	2 740	62 416	10 737	18 943
Other Disposals Decrease In Depreciation Impairment Property Plant Equipment				169	32 153	2 718	65 634	17 954
Other Disposals Intangible Assets
Other Disposals Property Plant Equipment				10 726	79 286	9 404	78 494	39 859
Other Interest Expense
Other Operating Income Format1									-2 423
Other Provisions Balance Sheet Subtotal							129 689	130 882	132 767
Other Taxation Social Security Payable			2 186	4 249	8 215	14 239	191 880	156 121
Par Value Share	1	1	1	1	1
Pension Other Post-employment Benefit Costs Other Pension Costs							9 343	12 656	20 343
Prepayments								27 597	19 785
Prepayments Accrued Income							6 314	27 597
Profit Loss							1 561 217	3 036 741	1 231 103
Profit Loss On Ordinary Activities Before Tax							1 934 301	3 805 180	1 532 111
Property Plant Equipment Gross Cost			430 977	622 568	631 253	848 685	1 185 344	1 627 219	2 204 186
Property Plant Equipment Including Right-of-use Assets								758 298	845 430
Provisions							167 756	182 462
Provisions For Liabilities Balance Sheet Subtotal							167 756	182 462
Social Security Costs							43 253	88 022
Staff Costs Employee Benefits Expense							529 278	1 026 648	1 274 085
Taxation Including Deferred Taxation Balance Sheet Subtotal							38 067	51 580
Tax Expense Credit Applicable Tax Rate							367 517	722 984	291 101
Tax Increase Decrease From Effect Capital Allowances Depreciation							5 567	-17 215
Tax Increase Decrease From Effect Expenses Not Deductible In Determining Taxable Profit Or Loss								6 165	19 341
Tax Tax Credit On Profit Or Loss On Ordinary Activities							373 084	768 439	328 543
Total Additions Including From Business Combinations Property Plant Equipment				202 317	87 971	226 836
Total Assets Less Current Liabilities			-180 508	-331 797	39 822	108 606	1 734 690	5 180 149
Total Current Tax Expense Credit							349 916	754 926
Trade Creditors Trade Payables			15 608	68 899	37 783	56 530	416 397	832 210	1 569 190
Trade Debtors Trade Receivables			198 475	178 218	307 536	470 785	1 153 589	932 326	867 169
Transfers To From Non-current Assets Or Disposal Groups Held For Sale Property Plant Equipment								-1 519
Transfer To Non-current Assets Or Disposal Groups Held For Sale Decrease In Depreciation Impairment Property Plant Equipment								-590
Turnover Revenue							5 107 189	9 193 543
Wages Salaries							476 682	925 970	1 135 133
Company Contributions To Defined Benefit Plans Directors							3 126	8 608
Company Contributions To Money Purchase Plans Directors								8 608
Director Remuneration							104 200	151 217
Director Remuneration Benefits Including Payments To Third Parties							107 326	159 825
Consideration For Shares Issued	1
Creditors Due Within One Year	154 671	431 115	936 797
Nominal Value Shares Issued	1
Number Shares Allotted	1	1	1
Number Shares Issued	1
Value Shares Allotted	1	1	1

Company staff

Scott G.

Role: Director

Appointed: 03 March 2022

Latest update: 14 March 2024

Marco C.

Role: Director

Appointed: 31 August 2022

Resigned: 05 February 2024

Latest update: 14 March 2024

Richard H.

Role: Director

Appointed: 20 August 2013

Resigned: 24 May 2021

Latest update: 14 March 2024

Keith S.

Role: Director

Appointed: 29 April 2013

Resigned: 31 August 2022

Latest update: 14 March 2024

Kevin B.

Role: Secretary

Appointed: 29 April 2013

Resigned: 04 September 2013

Latest update: 14 March 2024

People with significant control

Ralph D.

Notified on 31 August 2022

Nature of control:

over 1/2 to 3/4 of shares

over 1/2 to 3/4 of voting rights

right to manage directors

Clinical Evidence Enterprises Pty. Ltd.

Address: PO BOX 465, Cronulla, NSW 2230, Australia

Legal authority Australian

Legal form Australian Private Company

Country registered Australia

Place registered Australian Securities & Investments Commission

Registration number Abn 68 612 058 367

Notified on 29 April 2017

Ceased on 31 August 2022

Nature of control:

over 3/4 of shares

3/4 to full of voting rights

Accounts Documents

Account next due date	30 September 2024
Account last made up date	30 June 2022
Confirmation statement next due date	13 May 2024
Confirmation statement last made up date	29 April 2023

Annual Accounts
Start Date For Period Covered By Report	2013-04-29
Annual Accounts 23 March 2016
Start Date For Period Covered By Report	2014-07-01
End Date For Period Covered By Report	2015-06-30
Date Approval Accounts	23 March 2016
Annual Accounts 18 January 2017
Start Date For Period Covered By Report	2015-07-01
End Date For Period Covered By Report	2016-06-30
Date Approval Accounts	18 January 2017
Annual Accounts
Start Date For Period Covered By Report	2016-07-01
End Date For Period Covered By Report	2017-06-30
Annual Accounts
Start Date For Period Covered By Report	2017-07-01
End Date For Period Covered By Report	2018-06-30
Annual Accounts
Start Date For Period Covered By Report	2018-07-01
End Date For Period Covered By Report	2019-06-30
Annual Accounts
Start Date For Period Covered By Report	2019-07-01
End Date For Period Covered By Report	2020-06-30
Annual Accounts
Start Date For Period Covered By Report	2020-07-01
End Date For Period Covered By Report	2021-06-30
Annual Accounts
Start Date For Period Covered By Report	2021-07-01
End Date For Period Covered By Report	2022-06-30
Annual Accounts
Start Date For Period Covered By Report	2022-07-01
End Date For Period Covered By Report	2023-12-31
Annual Accounts 8 January 2015
End Date For Period Covered By Report	30 June 2014
Date Approval Accounts	8 January 2015

Ausdiagnostics Uk Limited

General information

Name:

Office Address:

Description

Financial data based on annual reports

Company staff

Scott G.

Marco C.

Richard H.

Keith S.

Kevin B.

People with significant control

Ralph D.

Clinical Evidence Enterprises Pty. Ltd.

Accounts Documents

Company filings

Filing category

Search other companies

Services (by SIC Code)

Company Age

Closest Companies - by postcode